IRIS
SCARPELLI, Marina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 18.441
EU - Europa 7.927
AS - Asia 6.396
SA - Sud America 1.714
AF - Africa 369
Continente sconosciuto - Info sul continente non disponibili 19
OC - Oceania 5
Totale 34.871
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 18.247
SG - Singapore 2.505
UA - Ucraina 1.559
BR - Brasile 1.464
CN - Cina 1.090
RU - Federazione Russa 1.012
IE - Irlanda 995
SE - Svezia 864
DE - Germania 858
HK - Hong Kong 831
IT - Italia 826
TR - Turchia 777
DK - Danimarca 575
VN - Vietnam 458
FI - Finlandia 368
GB - Regno Unito 344
KR - Corea 318
FR - Francia 231
CI - Costa d'Avorio 229
IN - India 140
AR - Argentina 93
CA - Canada 84
MX - Messico 81
NL - Olanda 72
EC - Ecuador 59
ID - Indonesia 55
PL - Polonia 52
MA - Marocco 49
ZA - Sudafrica 45
BD - Bangladesh 40
JP - Giappone 39
BE - Belgio 36
ES - Italia 28
CO - Colombia 22
PY - Paraguay 22
IQ - Iraq 21
AT - Austria 19
UZ - Uzbekistan 19
RO - Romania 18
VE - Venezuela 18
EU - Europa 17
EE - Estonia 16
AE - Emirati Arabi Uniti 15
PK - Pakistan 15
EG - Egitto 13
PE - Perù 13
CL - Cile 11
KZ - Kazakistan 9
CZ - Repubblica Ceca 8
SA - Arabia Saudita 8
TN - Tunisia 8
AZ - Azerbaigian 7
DZ - Algeria 7
KE - Kenya 7
NP - Nepal 7
AL - Albania 6
BG - Bulgaria 6
BO - Bolivia 6
LT - Lituania 6
AU - Australia 5
HN - Honduras 5
JO - Giordania 5
TT - Trinidad e Tobago 5
UY - Uruguay 5
AM - Armenia 4
AO - Angola 4
GR - Grecia 4
IR - Iran 4
LB - Libano 4
OM - Oman 4
BH - Bahrain 3
BY - Bielorussia 3
CH - Svizzera 3
DO - Repubblica Dominicana 3
IL - Israele 3
KG - Kirghizistan 3
RS - Serbia 3
BA - Bosnia-Erzegovina 2
BB - Barbados 2
DM - Dominica 2
ET - Etiopia 2
GD - Grenada 2
GE - Georgia 2
GT - Guatemala 2
HU - Ungheria 2
IS - Islanda 2
LU - Lussemburgo 2
MU - Mauritius 2
MY - Malesia 2
NI - Nicaragua 2
PA - Panama 2
PH - Filippine 2
PT - Portogallo 2
XK - ???statistics.table.value.countryCode.XK??? 2
BN - Brunei Darussalam 1
BS - Bahamas 1
CG - Congo 1
CR - Costa Rica 1
CY - Cipro 1
GP - Guadalupe 1
Totale 34.858
Salva come PNG Salva come JPEG
Città #
Chandler 1.751
Jacksonville 1.634
Ashburn 1.609
Singapore 1.522
Fairfield 1.437
Des Moines 1.201
Dallas 1.123
Dublin 993
Boardman 904
Hong Kong 826
Wilmington 816
Woodbridge 642
Seattle 581
Houston 567
New York 527
Cambridge 426
Lawrence 402
Princeton 402
San Mateo 390
Ann Arbor 290
Beijing 279
Abidjan 229
Centro 213
Los Angeles 204
Moscow 200
The Dalles 195
Hefei 177
Ho Chi Minh City 177
San Diego 177
Milan 164
São Paulo 130
Munich 116
Hanoi 99
London 93
Chicago 87
Pune 75
Buffalo 68
Washington 62
Shanghai 56
Turku 53
Redmond 46
Guangzhou 45
Mexico City 44
Norwalk 44
Columbus 42
Rio de Janeiro 42
Santa Clara 42
Warsaw 42
Turin 40
Wuhan 39
Izmir 37
Tokyo 35
Brussels 34
Council Bluffs 34
Helsinki 33
Salt Lake City 33
Curitiba 32
Atlanta 31
Brooklyn 31
Montreal 31
Ancona 29
Falls Church 29
Porto Alegre 27
Belo Horizonte 26
Denver 26
Guayaquil 26
Johannesburg 26
Phoenix 26
Jiaxing 23
Stockholm 23
Brasília 22
Haiphong 22
Orem 21
San Francisco 21
Elk Grove Village 20
Campinas 19
Marche 19
Ottawa 19
Amsterdam 18
Prescot 18
Seoul 18
Tashkent 18
Guarulhos 16
Manchester 16
Porto 16
Venice 16
Jakarta 15
Poplar 15
Quito 15
Salvador 15
Biên Hòa 14
Boston 14
Chennai 14
Kilburn 14
Yiwu 14
Fayetteville 13
Fortaleza 13
Wuxi 13
Da Nang 12
Nuremberg 12
Totale 22.407
Salva come PNG Salva come JPEG
Nome #
Morphometric index of adult renal cell carcinoma. Comparison with the Fuhrman grading system. 185
Prostatic Intraepithelial Neoplasia - Development of A Bayesian Belief Network For Diagnosis and Grading. 182
Are liver nested stromal epithelial tumors always low aggressive? 178
Mismatch repair deficiency may affect clinical outcome through immune response activation in metastatic gastric cancer patients receiving first-line chemotherapy 176
Ageing-related expression of Twinfilin-1 regulates cholangiocyte biological response to injury 172
Immunotherapy in genitourinary cancers: Where are we going? 171
Angiogenesis genotyping and clinical outcome during regorafenib treatment in metastatic colorectal cancer patients 167
BAP1, PBRM1 and SETD2 in clear-cell renal cell carcinoma: Molecular diagnostics and possible targets for personalized therapies 162
Impact of VEGF, VEGFR, PDGFR, HIF and ERCC1 gene polymorphisms on thymic malignancies outcome after thymectomy 161
2004 WHO classification of the renal tumors of the adults. 158
Transcontinental communication and quantitative digital histopathology via the Internet; with special reference to prostate neoplasia 156
A germline missense mutation in exon 3 of the MSH2 gene in a Lynch syndrome family: correlation with phenotype and localization assay 156
Biological issues with cabozantinib in bone metastatic renal cell carcinoma and castration-resistant prostate cancer 154
Chromosomal Abnormalities in Macroscopically Normal Urothelium in Patiens with Bladder pT1 and pT2a Urothelial Carcinoma: a Fluorescence in situ hybridisation Study and Correlation with Histologic Features. 148
Re: Umberto Leone Roberti Maggiore, Simone Ferrero, Massimo Candiani, et al. Bladder Endometriosis: A Systematic Review of Pathogenesis, Diagnosis, Treatment, Impact on Fertility, and Risk of Malignant Transformation. Eur Urol 2017;71:790–807 148
"Pathological" reflection on European urology: extended, saturation, and systematic prostate biopsies. 146
Lgr5 expression, cancer stem cells and pancreatic cancer: Results from biological and computational analyses 146
Metabolic phenotype of bladder cancer 146
Germline and somatic mutations in prostate cancer: Focus on defective DNA repair, PARP inhibitors and immunotherapy 145
Standardized mitotic counts in breast cancer evaluation of the method 143
2004 World Health Organization Classification of the Noninvasive Urothelial Neoplasms: Inherent Problems and Clinical Reflections 141
Androgen Receptor Signaling Pathway in Prostate Cancer: From Genetics to Clinical Applications 140
A rare case of chordoma and craniopharyngioma treated by an endoscopic endonasal, transtubercular transclival approach. 138
KRAS: To be or not to be targeted? Biologic and computational analyses in pancreatic adenocarcinoma 138
Secondary neoplasms of the urinary system and male genital organs. 135
Endoscopy-verified occult subependymal dissemination of glioblastoma and brain metastasis undetected by MRI: prognostic significance. 134
Biomarkers of aggressiveness in genitourinary tumors with emphasis on kidney, bladder, and prostate cancer 134
A new germline point mutation in Ret exon 8 (cys515ser) in a family with medullary thyroid carcinoma 133
KRAS mutation status is associated with specific pattern of genes expression in pancreatic adenocarcinoma 130
Epithelial to Mesenchymal Transition in Renal Cell Carcinoma: Implications for Cancer Therapy 130
Prospective study of a molecular selection profile for RAS wild type colorectal cancer patients receiving irinotecan-cetuximab 130
Activity of chemokines in prostate and renal tumors and their potential role as future therapeutic targets 129
Microbiome and cancers, with focus on genitourinary tumors 129
An observational retrospective analysis of the main metastatic site and corresponding locoregional treatment as a prognostic factor in metastatic gastric cancer 129
The role of angiogenetic single-nucleotide polymorphisms in thymic malignancies and thymic benign lesions 128
Adjuvant and neoadjuvant approaches for urothelial cancer: Updated indications and controversies 127
Morphologic, Molecular and Clinical Features of Aggressive Variant Prostate Cancer 126
Seminoma Retroperitoneal Relapse 23 Years After Surgery 126
Meningioma-like cerebral relapse of Hodgkin's disease. 125
HER2 expression and gene amplification in pT2a Gleason score 6 prostate cancer incidentally detected in cystoprostatectomies: comparison with clinically detected andreogen-dependent and androgen-independent cancer. 124
Morphologic Variants of Epithelial and Neuroendocrine Tumors of the Prostate. The Pathologist's Point of View 124
Nuclear changes in the normal-looking columnar epithelium adjacent to and distant from prostatic intraepithelial neoplasia and prostate cancer. Morphometric analysis in whole-mount sections. 123
2009 update on the classification of renal epithelial tumors in adults 123
Active surveillance for low-risk prostate cancer. 123
Oligometastases in Genitourinary Tumors: Recent Insights and Future Molecular Diagnostic Approach 122
Angioblastic parasellar extradural tumours. 121
HER family receptor expression and prognosis in pancreatic cancer 121
Basal cell hyperplasia and basal cell carcinoma of the prostate: a comprehensive review and discussion of a case with c-erbB-2 expression. 119
Subarachnoid haemorrhage due to widely metastatising malignant ependymoma. 119
Metabolic Alterations in Renal and Prostate Cancer 119
Rare synchronous association of vestibular schwannoma and indolent insular oligodendroglioma in a patient without neurofibromatosis: controversial issue of timing for surgical treatment of asymptomatic low-grade gliomas. 119
Contemporary best practice in the management of urothelial carcinomas of the renal pelvis and ureter 119
Adjuvant therapy in renal cell carcinoma: Is it the right strategy to inhibit VEGF? 119
Immunohistochemical expression of somatostatin receptor subtypes in prostate tissue from cystoprostatectomies with incidental prostate cancer. 116
A low grade PIN-like neoplasm of the transition zone immunohistochemically negative for basal cell markers: a possible example of low grade adenocarcinoma with stratified epithelium. 116
Computer assisted discrimination of glioblastomas 115
Adult primary paratesticular mesenchymal tumors with emphasis on a case presentation and discussion of spermatic cord leiomyosarcoma. 114
Resistance to systemic agents in renal cell carcinoma predict and overcome genomic strategies adopted by tumor 114
Pseudoxanthoma elasticum and skin: Clinical manifestations, histopathology, pathomechanism, perspectives of treatment 113
Seminal Vesicle Intraepithelial Neoplasia Versus Basal Cell Hyperplasia in a Seminal Vesicle. 112
Morphological diagnosis of urothelial neoplasms. 112
[Intracranial pressure in traumatic brain laceration and intracerebral hematomas (author's transl)]. 112
From undergraduate medical school student to visible pathologist 112
Improving inter-observer agreement and certainty level in diagnosing and grading papillary urothelial neoplasms: usefulness of a Bayesian belief network. 111
Epileptogenic Low-Grade Tumours in Childhood: Outcome after Lesionectomy 111
"No pay, no play" or from "defensive or passive pathology" to "active, clinically oriented pathology" 111
SURGICAL TREATMENT FOR GLIOBLASTOMA MULTIFORME: OUTCOME AND ANALYSIS OF PROGNOSTIC FACTORS ESPECIALLY ORIENTED TO THE EXTENT OF SURGICAL RESECTION 111
An overview of emerging immunotargets of genitourinary tumors 111
An evaluation of current prostate cancer diagnostic approaches with emphasis on liquid biopsies and prostate cancer 111
A contemporary update on pathology reporting for urinary bladder cancer. 110
Re: Daniel M. Geynisman. Anti-programmed cell death protein 1 (PD-1) antibody nivolumab leads to a dramatic and rapid response in papillary renal cell carcinoma with sarcomatoid and rhabdoid features. Eur Urol 2015;68:912–4 110
Cardiac myxoma with glandular elements metastatic to the brain 12 years after the removal of the original tumor 109
Genitourinary cancers: molecular determinants for personalized therapies 109
Impact of phosphoinositide-3-kinase and vitamin D3 nuclear receptor single-nucleotide polymorphisms on the outcome of malignant melanoma patients 109
Pd-l1 inhibitors for the treatment of prostate cancer 109
Is There a Role for Immunotherapy in Prostate Cancer? 109
MRI and pathological examination of post-mortem brains: the problem of white matter high signal areas. 108
Urothelial papillary lesions. Development of a Bayesian Belief Network for diagnosis and grading 107
[Magnetic resonance in the pathologic evaluation of the isolated human brain]. 107
Granular osmiophilic material-containing pseudoinclusions in CADASIL 107
TGFb1 immunohistochemistry in goiter; comparison of patients with recurrence or non recurrence 106
Added Clinical Value of Whole-mount Histopathology of Radical Prostatectomy Specimens: A Collaborative Review 106
alpha-Methylacyl coenzyme A racemase, Ki-67, and topoisomerase IIalpha in cystoprostatectomies with incidental prostate cancer 105
Contemporary grading of prostate cancer: 2017 update for pathologists and clinicians 105
RAS genes in colorectal carcinoma: Pathogenesis, testing guidelines and treatment implications 105
Biphasic Tumors of the Urogenital Tract: Selected Topics 105
Quantitative-analysis of Prostatic Intraepithelial Neoplasia On Tissue-sections. 104
Bone targeting agents in patients with metastatic prostate cancer: State of the art 104
Narrative review of prostate cancer grading systems: Will the Gleason scores be replaced by the grade groups? 104
Present and future of personalized medicine in adult genitourinary tumors 103
Epigenetic modifications and modulators in prostate cancer 102
Current and emerging bladder cancer biomarkers with an emphasis on urine biomarkers 102
Bladder cancer: molecular determinants of personalized therapy 102
Immunotherapy in renal cell carcinoma: latest evidence and clinical implications 101
Pseudocarcinomatous hyperplasia associated with primary lymphoma in the urinary bladder: a case report 101
[Significance of intracranial hypertension in craniocerebral trauma]. 100
Mitochondrial encephalomyopathy lactic acidosis and strokelike episodes mimicking occipital idiopathic epilepsy. 100
[Peripheral neuropathy associated with Castleman's lymphoma]. 100
Computer assisted analysis of medulloblastoma: a cytological study 100
Acne agminata in Crohn's disease: A diagnostic and therapeutic challenge case for dermatologists 100
Totale 12.448
Salva come PNG Salva come JPEG
Categoria #
all - tutte 189.188
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 189.188
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213.497 0 0 0 0 0 722 481 443 495 552 572 232
2021/20223.031 317 620 95 136 28 269 82 202 192 273 190 627
2022/20235.798 523 459 326 462 379 1.580 3 350 1.303 34 267 112
2023/20243.068 555 78 200 429 510 696 53 75 6 53 26 387
2024/20256.021 657 522 240 141 214 222 560 262 1.535 462 505 701
2025/20266.381 787 1.103 1.098 1.586 1.508 299 0 0 0 0 0 0
Totale 35.283